Quality/QA Solutions for CDMO
Assyro AI empowers quality assurance professionals in contract development and manufacturing organizations with intelligent regulatory tools. Assyro AI helps quality assurance professionals maintain GxP compliance, track regulatory inspections, and ensure documentation integrity. Stay audit-ready and proactively address quality issues with AI-powered intelligence.
What Quality/QA Teams Do
- Ensuring GMP/GLP/GCP compliance across operations
- Managing quality systems and documentation
- Preparing for and responding to regulatory inspections
- Overseeing deviation management and CAPA processes
- Maintaining training and qualification records
Challenges in CDMO
- Managing increasing inspection scrutiny and expectations
- Tracking evolving GxP regulations and guidance
- Maintaining comprehensive audit trails and documentation
- Sponsors return CMC packages for revisions 2-3 times before acceptance, costing weeks per cycle
- GMP regulation tracking across FDA, EMA, and PMDA is manual and always behind
How Assyro AI Helps
- Track GxP regulation changes and enforcement trends
- Monitor FDA warning letters and 483 observations
- Generate inspection-ready documentation
- Build Module 3 packages with real-time validation that catch defects before sponsor review
- Track GMP regulation changes across FDA, EMA, and PMDA automatically with actionable alerts
Key Skills We Support
Regulations We Cover
Frequently Asked Questions
Assyro AI helps QA professionals track GxP regulations, monitor FDA enforcement actions, and maintain compliance documentation. Our AI alerts you to inspection trends and helps prepare responses to observations.
Yes, Assyro AI helps QA teams prepare for inspections by tracking common 483 observations, monitoring warning letters in your industry, and ensuring your documentation is inspection-ready.
Assyro AI comprehensively covers GMP, GCP, GLP, and other GxP frameworks across FDA, EMA, and global agencies. We monitor guidance updates and alert you to changes that impact your quality systems.
Assyro validates Module 3 documentation continuously as your team builds it. Structural gaps, formatting errors, and missing references are flagged before the package reaches the sponsor. Teams go from 3 revision rounds to 1.
Yes. Assyro analyzes common 483 observations, provides structured response templates, and pulls in precedent corrective actions. Teams draft responses in hours instead of weeks.
Regulatory Context
Quality/QA teams in CDMO depend on current regulatory intelligence to keep submissions, quality narratives, and inspection responses aligned with health-authority expectations.
Common Mistakes
- Only reviewing quality records during inspections instead of continuously.
- Missing trend analysis across recurring deviations and CAPAs.
- Separating compliance tracking from regulatory change monitoring.
Key Regulatory Terms
Regulations ensuring pharmaceutical products are consistently produced and controlled according to quality standards.
A systematic approach to identifying, investigating, and addressing the root causes of quality problems.
A departure from an approved procedure, specification, or established standard during manufacturing or testing.
Relevant Regulatory Intelligence
Related Actions
Other Roles in CDMO
Quality/QA in Other Industries
Ready to Transform Your Quality/QA Operations?
See how Assyro AI can accelerate regulatory work for quality assurance professionals in contract development and manufacturing organizations.
Schedule a Demo